...
首页> 外文期刊>Annals of surgical oncology >Natural History of Gastric Cancer: Observational Study of Gastric Cancer Patients Not Treated During Follow-Up
【24h】

Natural History of Gastric Cancer: Observational Study of Gastric Cancer Patients Not Treated During Follow-Up

机译:胃癌的自然历史:在随访期间未治疗的胃癌患者的观察研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background Understanding the natural progression of untreated gastric cancer is critical for determining the disease prognosis as well as treatment options and timing. The aim of this study is to analyze the natural history of gastric cancer. Patients and Methods We included patients with gastric cancer who had not received any treatment and were staged using endoscopy/endoscopic ultrasonography and computed tomography on at least two follow-up visits during intervals of nontreatment. Tumor volumes were also measured in addition to the staging. Survival of each stage at diagnosis was also analyzed. Results A total of 101 patients were included. The mean follow-up period was 35.1 +/- 34.4 months. The gastric cancer doubling time was 11.8 months for T1 and 6.2 months for T4. The progression time from early gastric cancer to advanced gastric cancer was 34 months. It decreased as the stages advanced: from 34 months between tumor-nodes-metastasis stage I and II to 1.8 months between stage III and IV. No variable was identified as a risk factor for cancer progression. The 5-year survival rates of untreated patients were 46.2% in stage I and 0% in stage II, stage III, and stage IV. Conclusions The progression and doubling times of gastric cancer shorten as the stages advance. Objective data reported in this study can be a critical factor in determining treatment timing and screening interval.
机译:背景技术了解未处理的胃癌的自然进展对于确定疾病预后以及治疗方案和时序至关重要。本研究的目的是分析胃癌的自然历史。患者和方法我们包括患有任何未接受任何治疗的胃癌患者,并使用内窥镜检查/内窥镜超声检查和计算断层扫描,并在非处理的间隔期间至少进行两次后续访问。除了分段之外还测量肿瘤体积。还分析了每个阶段的生存率。结果总共包括101名患者。平均随访时间为35.1 +/- 34.4个月。 T4的T1和6.2个月的胃癌倍增时间为11.8个月。早期胃癌到晚期胃癌的进展时间为34个月。它随着阶段的阶段减少:从肿瘤节点 - 转移阶段I和II之间的34个月至第III期和IV之间的1.8个月。没有变量被鉴定为癌症进展的危险因素。未经治疗的患者的5年生存率在第I期和第II期,第III期和第四阶段的0%均为46.2%。结论胃癌的进展和倍增时间缩短为阶段预期。本研究报告的目的数据可以是确定治疗时间和筛选间隔的关键因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号